4/11
09:06 am
ebs
Emergent BioSolutions Inc. (NYSE: EBS) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $5.00 price target on the stock.
Low
Report
Emergent BioSolutions Inc. (NYSE: EBS) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $5.00 price target on the stock.
4/11
09:06 am
ebs
Emergent BioSolutions Inc. (NYSE: EBS) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $5.00 price target on the stock.
Low
Report
Emergent BioSolutions Inc. (NYSE: EBS) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $5.00 price target on the stock.
4/11
09:03 am
ebs
Rating for EBS
Low
Report
Rating for EBS
4/11
09:03 am
ebs
Rating for EBS
Low
Report
Rating for EBS
3/7
10:37 am
ebs
Rating for EBS
Medium
Report
Rating for EBS
3/7
10:37 am
ebs
Rating for EBS
Medium
Report
Rating for EBS
3/7
10:18 am
ebs
Emergent BioSolutions Inc. (NYSE: EBS) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating. They now have a $5.00 price target on the stock.
Medium
Report
Emergent BioSolutions Inc. (NYSE: EBS) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating. They now have a $5.00 price target on the stock.
3/7
10:18 am
ebs
Emergent BioSolutions Inc. (NYSE: EBS) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating. They now have a $5.00 price target on the stock.
Medium
Report
Emergent BioSolutions Inc. (NYSE: EBS) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating. They now have a $5.00 price target on the stock.